市場調查報告書
商品編碼
1541685
膠囊內視鏡市場報告(依產品(小腸、食道、結腸)、配件(無線膠囊、工作站和記錄器)、應用(OGIB、克隆氏症、小腸腫瘤)和地區 2024-2032Capsule Endoscopy Market Report by Product (Small Bowel, Esophageal, Colon), Accessory (Wireless Capsule, Workstation and Recorder), Application (OGIB, Crohn's, Small Intestine Tumors), and Region 2024-2032 |
2023年全球膠囊內視IMARC Group市場規模達4.859億美元。
膠囊內視鏡檢查是指用於取得食道、胃和小腸影像的診斷程序。它涉及使用小型膠囊封裝的相機,該相機被吞下並通過胃腸道(GI)。此手術是微創(MI)、無痛且不需要麻醉。它使醫生能夠拍攝數千張內臟器官的圖像,這是透過傳統使用的成像解決方案無法獲得的。因此,膠囊內視鏡廣泛應用於胃腸道癌症、慢性腹痛、克隆氏症、乳糜瀉、出血過多和潰瘍等疾病的診斷和治療。
全球胃腸道疾病和大腸癌盛行率的增加是推動市場成長的關鍵因素之一。此外,大眾對治療此類疾病的無痛和心肌梗塞可視化手術的認知不斷提高,這也推動了市場的成長。食道、小腸和結腸膠囊內視鏡廣泛應用於醫院和其他醫療中心,用於及時診斷和改善患者護理。與此一致的是,老年人口的增加也促進了市場的成長,老年人口更容易患發炎性腸道疾病、不明性胃腸道出血(OGIB)和闌尾炎等疾病。此外,各種技術進步,例如具有更長電池壽命和 Wi-fi 相容性的膠囊的開發,也是其他促進成長的因素。產品製造商也在開發方便用戶使用的、具有 360 度全景的高解析度相機。其他因素,包括消費者支出能力的提高以及醫療保健基礎設施的廣泛改善,預計將推動市場成長。
The global capsule endoscopy market size reached US$ 485.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 938.4 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Capsule endoscopy refers to a diagnostic procedure used for obtaining images of the esophagus, stomach and small intestines. It involves the use of a small capsule-encased camera, which is swallowed and passed through the gastrointestinal (GI) tract. The procedure is minimally invasive (MI), painless and does not require the administration of anesthesia. It enables the physician to take thousands of images of the internal organs which are not accessible through the traditionally used imaging solutions. As a result, capsule endoscopy is widely used in the diagnosis and treatment of gastrointestinal cancer, chronic abdominal pain, Crohn's disease, celiac disease, excessive bleeding and ulcers.
The increasing prevalence of gastrointestinal disorders and colorectal cancer across the globe is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the availability of painless and MI visualization procedures for the treatment of such ailments is providing a thrust to the market growth. Esophageal, small bowel and colon capsule endoscopes are extensively used across hospitals and other healthcare centers for timely diagnosis and improved patient care. In line with this, the rising geriatric population, which is more susceptible to ailments, such as inflammatory bowel disease, Obscure Gastrointestinal Bleeding (OGIB) and appendicitis, is also contributing to the growth of the market. Additionally, various technological advancements, such as the development of capsules with longer battery life and Wi-fi compatibility, are acting as other growth-inducing factors. Product manufacturers are also developing user-friendly and high-resolution cameras with a 360-degree panoramic view. Other factors, including rising expenditure capacities of the consumers, along with extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global capsule endoscopy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, accessory and application.
Small Bowel
Esophageal
Colon
Wireless Capsule
Workstation and Recorder
OGIB
Crohn's
Small Intestine Tumors
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CapsoVision Inc., Check Cap Ltd, Fujifilm Holdings Corporation, IntroMedic Co. Ltd, Jinshan Science & Technology (Group) Co. Ltd., Medtronic plc, Olympus Corporation, RF Co. Ltd. and Shangxian Minimal Invasive Inc.